Teleflex Catheter Kit Issues Lead to Mass Recalls

According to the FDA, Teleflex has pulled back catheter kits associated with 31 injuries and 3 fatalities.

The recall pertains to about 17,000 catheter kits that were supplied in the United States throughout May 2022 and April 2024 by Teleflex and its subsidiary Arrow International. These gadgets with balloon pumps are used by doctors to treat acute coronary syndrome and cardiovascular problems.

According to the FDA, Blood loss, arterial rips, erratic levels of blood pressure, and obstruction of cardiac blood flow are possible side effects.

The FDA has classified the action as a Class I recall since the consequences have the potential to result in significant damage or fatalities.

Teleflex CEO Liam Kelly discussed the latest catheter recall explaining to investors that the “the financial impact from the voluntary field action to be immaterial.”